Richard A. Keys - 11 Feb 2022 Form 4 Insider Report for RAPID MICRO BIOSYSTEMS, INC. (RPID)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 Feb 2022, 18:37:34 UTC
Prior SEC filing
05 Oct 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Paris, Attorney-in-Fact for Richard A. Keys

Key filing fact

Richard A. Keys filed Form 4 for RAPID MICRO BIOSYSTEMS, INC. (RPID) on 15 Feb 2022.

Key facts

  • This page summarizes Richard A. Keys's Form 4 filing for RAPID MICRO BIOSYSTEMS, INC. (RPID).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Feb 2022, 18:37.

Change

  • Previous filing in this sequence was filed on 05 Oct 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPID transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+43,750
Change %
Price
$0.000000
Shares after
43,750
Date
11 Feb 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPID transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+87,500
Change %
Price
$0.000000
Shares after
87,500
Date
11 Feb 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
87,500
Exercise price
$7.82
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of February 11, 2022 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

Footnote F2

The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 11, 2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .